{"groups":[{"description":"Patients receive cyclosporine ophthalmic emulsion (Restasis®) drops in each eye twice daily for up to 1 year after transplant.\n\ncyclosporine ophthalmic emulsion: Given as eye drops","id":"FG000","title":"Arm I"},{"description":"Patients receive placebo ophthalmic drops in each eye twice daily for up to 1 year after transplant.\n\nplacebo: Given as eye drops","id":"FG001","title":"Arm II"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"83"},{"groupId":"FG001","numSubjects":"81"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"40"},{"groupId":"FG001","numSubjects":"47"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"43"},{"groupId":"FG001","numSubjects":"34"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}